Search Results - "Ubieto, A. Jiménez"

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma by Kim, T M, Taszner, M, Novelli, S, Cho, S-G, Villasboas, J C, Merli, M, Jiménez-Ubieto, A, Tessoulin, B, Poon, L M, Tucker, D, Walewski, J, Yi, S, Song, Y, Chong, G, Bachy, E, Guidez, S, Alonso, A, Jagadeesh, D, Zhang, W, Magnano, L, Iskierka-Jażdżewska, E, Tani, M, Shen, B, Uppala, A, Zhu, M, Shariff, S, Brouwer-Visser, J, Chaudhry, A, Mohamed, H, Ambati, S, Luminari, S

“…Odronextamab, a CD20×CD3 bispecific antibody that engages cytotoxic T cells to destroy malignant B cells, has demonstrated encouraging activity across multiple…”
Get more information

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma by Lopez-Muñoz, N, Hernández-Ibarburu, G, Alonso, R, Sanchez-Pina, J M, Ayala, R, Calbacho, M, Cuellar, C, Cedena, M T, Jiménez-Ubieto, A, Iñiguez, R, Pedrera, M, Cruz, J, Meloni, L, Pérez-Rey, D, Serrano, P, de la Cruz, J, Martinez-Lopez, J

“…Survival in multiple myeloma has improved significantly in recent years, especially in young patients. We reviewed the evolution of the survival of patients…”
Get full text

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma by Lopez-Muñoz, N, Hernández-Ibarburu, G, Alonso, R, Sanchez-Pina, J M, Ayala, R, Calbacho, M, Cuellar, C, Cedena, M T, Jiménez-Ubieto, A, Iñiguez, R, Pedrera, M, Cruz, J, Meloni, L, Pérez-Rey, D, Serrano, P, de la Cruz, J, Martinez-Lopez, J

Get full text

P1132: PET INTERIM RESULTS PREDICT PROGRESSION‐FREE‐SURVIVAL IN FOLLICULAR LYMPHOMA PATIENTS WITH ADVANCED STAGE by Poza, M., Zamanillo, I., Íñiguez, R., Sarandeses, P., Rodriguez, A., Baumann, T., Barrio, S., Grande, C., Martin, A., Rufian, L., Martinez‐Lopez, J., Jiménez‐Ubieto, A.

Get full text

Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO) by García-Noblejas, A., Cannata-Ortiz, J., Conde, E., González Barca, E., Gutiérrez, N., Rojas, R., Vidal, M.J., Ramírez, M.J., Jiménez-Ubieto, A., García-Ruiz, J.C., Sancho, J. M., López, A., Ríos Rull, P., Novelli, S., Albo, C., Debén, G., López-Guillermo, A., Nicolás, C., González de Villambrosia, S., Mercadal, S., Martín García-Sancho, A., Arranz, R.

“…Guidelines recommend autologous stem cell transplantation (ASCT) consolidation in first complete or partial response after regimens including rituximab (R) and…”
Get full text

PET interim results could promptly select Follicular Lymphoma patients in need of maintenance therapy. Potential additional value of ctDNA by Jiménez‐Ubieto, A., Poza, M., López‐Pereira, P., Figaredo, G., Sarandeses, P., Martin‐Muñoz, A., Barrio, S., Cortés, M., Íñiguez, R., Zamanillo, I., Oliveira, A., Rodríguez‐Izquierdo, A., Baumann, T., Revilla, E., Gómez‐Rojas, S., Pérez‐Segura, G., Ayala, R., Martínez‐López, J.

Get full text

FIVE‐YEAR UPDATE OF THE FIRST‐LINE IMCL‐2015 GELTAMO STUDY. PROLONGED MOLECULAR AND CLINICAL RESPONSES WERE OBSERVED AFTER MRD‐DRIVEN IBRUTINIB DISCONTINUATION by Giné, E., Medina‐Herrera, A., Cruz, F. de la, Ubieto, A. Jiménez, Jiménez, J. López, García‐ Sancho, A. Martín, Terol, M J., Barca, E. González, Casanova, M., Fuente, A. de la, Niebla, A. Marín, Muntañola, A., López, T. J. González, Aymerich, M., Setoain, X., Cortés‐Romera, M., Rotger, A., Rodríguez, S., López, C., Nadeu, F., Beà, S., Campo, E., Sanz, R. García, Guillermo, A. López

Get full text

UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA by Búa, B. Rey, Jiménez‐Ubieto, A., Blanco, J. J. Sánchez, Abrisqueta, P., Gutiérrez, A., Ramírez‐Páyer, Án., Giné, E., Etxetxipia, I. Zeberio, Terol, M. José, Cruz, F. de la, Andreu, R., Ramírez, M., Fuente, A. de la, Viguria, M., Peñarrubia, M., Grande, C., Montes‐Moreno, S., Barrigón, M. D. Caballero, García‐Sancho, A. Martín

Get full text

EFFICACY AND SAFETY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB AS FRONTLINE TREATMENT FOR INDOLENT CLINICAL FORMS OF MANTLE CELL LYMPHOMA. RESULTS OF THE GELTAMO IMCL‐2015 STUDY by Giné, E., De la Cruz, F., Ubieto, A. Jiménez, Jiménez, J. López, García‐Sancho, A. Martín, Terol, M. J., González‐Barca, E., Casanova, M., De la Fuente Burguera, A., Niebla, A. Marín, Prat, A. Muntanola, González‐López, T. J., Aymerich, M., Setoain, X., Cortés‐Romera, M., Rotger, A., Medina, A., García‐Sanz, R., Campo, E., López‐Guillermo, A.

Get full text

OUTCOME OF 133 PATIENTS WITH FOLLICULAR LYMPHOMA (FL) PROGRESSING BEFORE 24 MONTHS (POD24) AFTER IMMUNOCHEMOTHERAPY: A GELTAMO STUDY by Muntañola, A., Magnano, L., Mercadal, S., Huguet, M., Bobillo, S., Bastos‐Oreiro, M., Jiménez‐Ubieto, A., Rovira, J., Rivero, A., Alcoceba, M., Mozas, P., Luizaga, L., Alonso‐Álvarez, S., Rivas‐Delgado, A., Giné, E., Caballero, D., Sancho, J. M., López‐Guillermo, A.

Get full text

OUTCOMES OF PATIENTS WITH LYMPHOMA AND COVID‐19: AN OBSERVATIONAL COHORT STUDY FROM GELTAMO SPANISH GROUP by García‐Sancho, A. Martín, Izuzquiza, M., Bastos‐Oreiro, M., Baile, M., Nistal, S., Cortés, M., Jiménez‐Ubieto, A., Búa, B. Rey, Guillén‐García, H., Cannata‐Ortiz, J., Novelli, S., Gómez‐Roncero, M. I., Peñalver, F. J., Barca, E. M. González, Infante, M., Peñarrubia, M. Jesús, Franch, M., Alonso‐Prieto, C., Zeberio, I., Sánchez‐González, B., Muntañola, A., Hernández‐Mohedo, F., Martín‐Martitegui, X., Arguiñano, J. María, Campo, R. del, Escoda, L., Roldán‐Pérez, A., Ramírez‐Payer, Á., Luzardo, H., Lorente, S., Solé‐Rodríguez, M., Abrisqueta, P., Sancho, J. M.

Get full text

PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG‐TERM OUTCOME OF FOLICULAR LYMPHOMA by Zamanillo, I., Poza, M., Iñiguez, R., Barrio, S., Sarandeses, P., Martin, A., Rodriguez, A., Baumann, T., Rufian, L., Martinez‐Lopez, J., Jimenez‐Ubieto, A.

Get full text

P1284: LIQUID BIOPSY BY ULTRA-DEEP SEQUENCING PLUS PET-TC MONITORING IN REAL-LIFE FOLLICULAR LYMPHOMA PATIENTS by Jiménez-Ubieto, A., Poza Santaella, M., Martin, A., Heredia, Y., Dorado, S., Figaredo, G., Rufian, L., Rodriguez, A., Sarandeses, P., Baumann, T., Grande, C., Bárcena, C., Martinez-Lopez, J., Rosa, J.-M., Rapado, I., Ayala, R., Gallardo, M., Sánchez, R., Carrillo, J., Calbacho, M., Parrilla, L., Juarez, A., Mollejo, M., Casado, L. F., Wang, C., Rodriguez, M., De Toledo, P., Barrio, S.

Get full text

P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON‐HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR‐T THERAPY by Garcia‐Vicente, R., Rodriguez‐Garcia, A., Gomez‐Gordo, R., Ortega‐Hernandez, A., Ancos, R., Serrano, S., Modrego, J., Leivas, A., Valeri, A., Jimenez‐Ubieto, A., Sanchez‐Pina, J. M., Paciello, M. L., Gomez‐Garre, D., Martinez‐Lopez, J., Linares, M.

Get full text

AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA by Jiménez Ubieto, A., Grande, C., Caballero, D., Yañez, L., Novelli, S., Hernández‐Garcia, M., Manzanares, M., Arranz, R., Ferreiro, J., Bobillo, S., Mercadal, S., Galego, A., López‐Jiménez, J., Moraleda, J., Vallejo, C., Albo, C., Pérez‐Ceballos, E., Marrero, C., Magnano, L., Palomera, L., Jarque, I., Martín, A., Coria, E., López‐Guillermo, A., Salar, A., Lahuerta, J.

Get full text

PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN MAINTAINED COMPLETE RESPONSE (CR) AT 30 MONTHS SHOW A SURVIVAL SIMILAR TO A SEX‐ AND AGE‐MATCHED SPANISH GENERAL POPULATION by Magnano, L., Alonso‐Alvarez, S., Alcoceba, M., Rivas‐Delgado, A., Muntañola, A., Andrade‐Campos, M., Rodriguez, G., Sancho, J., Mercadal, S., Salar, A., Arranz, R., Terol, M., Jiménez‐Ubieto, A., González de Villambrosía, S., Bello, J., López, L., Novelli, S., De Cabo, E., Infante, M., Pardal, E., Canals, M., González, M., Martín, A., Caballero, M., López‐Guillermo, A.

Get full text

Icu and long-term mortality analisis of hematology patients admitted in icu. a 7 years review from a single spanish center by Garcia Gigorro, R, Jiménez-Ubieto, A, Marín, H, Morales-Varas, G, Grande-García, C, Montejo-González, JC

“…Issue Title: ESICM LIVES 2015…”
Get full text

Hemolytic Disease of the Newborn Due to Anti-Jkb: Case Report and Review of the Literature by Velasco Rodríguez, Diego, Pérez-Segura, G., Jiménez-Ubieto, A., Rodríguez, M. A., Montejano, L.

“…Although anti-Jkb is a well-defined cause of severe acute or delayed hemolytic transfusion reactions, it is rarely associated with severe Hemolytic Disease of…”
Get full text

Novel therapies for the treatment of relapsed‐refractory aggressive B‐cell lymphoma increase survival. Analysis from the RELINF registry of the GELTAMO group by Bastos‐Oreiro, M., Abrisqueta, P., Gutierrez, A., Jimenez‐Ubieto, A., Gonzalez de Villambrosia, S., Córdoba, R., López, A., Poza, M., Ceballos, E. Pérez, Navarro, B., Muntañola, A., Donato, E., Escoda, L., Luzardo, H., Peñarrubia, M. J., Pardal, E., Belmonte, D. García, Lozada, C. Salazar, García‐Sancho, A. Martín

Get full text

Personalized monitoring of circulating tumor DNA by a specific signature of trackable mutations after chimeric antigen receptor t‐cell therapy in non‐Hodgkin B cell lymphoma by Bastos, M., Barrio, S., Martin‐Muñoz, A., iglesia, I., Muñiz, P., Dorado, S., Bailen, R., Poza, M., Chicano, M., Garcia‐Ortiz, A., Diaz‐Crespo, F., Maria, S. Jose, Revilla, E., Valeri, A., Kwon, M., Martínez‐López, J., Buño, I., Martinez‐Laperche, C., Jimenez‐Ubieto, A.

Get full text